Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,992 | 78 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $631.63 | 6 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $602.15 | 10 | $0 (2024) |
| Lilly USA, LLC | $454.17 | 12 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $412.80 | 4 | $0 (2024) |
| GENZYME CORPORATION | $392.86 | 3 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $375.00 | 3 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $219.65 | 5 | $0 (2024) |
| Exact Sciences Corporation | $219.42 | 10 | $0 (2024) |
| Intuity Medical Inc | $207.71 | 2 | $0 (2023) |
| Astellas Pharma US Inc | $82.79 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,350 | 18 | Phathom Pharmaceuticals, Inc. ($412.80) |
| 2023 | $953.57 | 28 | Intuity Medical Inc ($207.71) |
| 2022 | $693.95 | 13 | Novo Nordisk Inc ($250.00) |
| 2021 | $994.29 | 19 | GENZYME CORPORATION ($267.86) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $25.03 | General |
| Category: VACCINES | ||||||
| 11/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Gastroenterology | ||||||
| 11/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 09/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/12/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $27.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/27/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Oncology | ||||||
| 08/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: Biological | ||||||
| 08/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Gastroenterology | ||||||
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 06/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $150.00 | General |
| Category: Diabetes | ||||||
| 04/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardio-renal | ||||||
| 04/10/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 03/05/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $134.99 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/27/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Oncology | ||||||
| 02/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Respiratory | ||||||
| 12/06/2023 | Intuity Medical Inc | Pogo Automatic Blood Glucose Monitoring System (Device) | Food and Beverage | Cash or cash equivalent | $136.28 | General |
| Category: Diabetes | ||||||
| 12/06/2023 | Intuity Medical Inc | Pogo Automatic Blood Glucose Monitoring System (Device) | Food and Beverage | Cash or cash equivalent | $71.43 | General |
| Category: Diabetes | ||||||
| 12/06/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Oncology | ||||||
| 11/15/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $28.93 | General |
| Category: VACCINES | ||||||
| 11/09/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Gastroenterology | ||||||
| 10/19/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/20/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 198 | 333 | $33,859 | $15,855 |
| 2022 | 6 | 160 | 301 | $32,467 | $15,106 |
| 2021 | 11 | 289 | 462 | $62,486 | $19,622 |
| 2020 | 13 | 360 | 572 | $75,351 | $18,377 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 137 | $16,413 | $8,056 | 49.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 57 | $10,313 | $4,508 | 43.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $4,754 | $1,449 | 30.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 18 | 19 | $571.90 | $560.50 | 98.0% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 11 | 12 | $812.16 | $522.01 | 64.3% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 12 | 17 | $541.96 | $429.25 | 79.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 55 | 79 | $453.00 | $330.54 | 73.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 176 | $24,548 | $12,002 | 48.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 15 | $4,477 | $1,491 | 33.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 16 | 20 | $2,290 | $792.77 | 34.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 15 | 15 | $451.50 | $442.50 | 98.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 18 | 20 | $355.20 | $214.44 | 60.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 40 | 55 | $345.00 | $162.60 | 47.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 67 | 186 | $22,245 | $11,518 | 51.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 24 | $16,620 | $2,389 | 14.4% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 29 | 35 | $7,000 | $1,796 | 25.7% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 28 | 40 | $3,029 | $1,501 | 49.5% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 12 | 19 | $7,600 | $691.80 | 9.1% |
| 87811 | Sars-cov-2 covid19 w/optic | Office | 2021 | 12 | 12 | $2,400 | $496.56 | 20.7% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 22 | 26 | $1,842 | $454.45 | 24.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 17 | 18 | $541.80 | $366.21 | 67.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 51 | 66 | $438.00 | $198.00 | 45.2% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 13 | 14 | $470.48 | $161.98 | 34.4% |
| 81003 | Automated urinalysis test | Office | 2021 | 20 | 22 | $299.88 | $49.50 | 16.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 74 | 187 | $23,319 | $9,568 | 41.0% |
About Leon Kohanbash, MS-FNP
Leon Kohanbash, MS-FNP is a Family healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1295914869.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Leon Kohanbash, MS-FNP has received a total of $3,992 in payments from pharmaceutical and medical device companies, with $1,350 received in 2024. These payments were reported across 78 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,992).
As a Medicare-enrolled provider, Kohanbash has provided services to 1,007 Medicare beneficiaries, totaling 1,668 services with total Medicare billing of $68,960. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Brooklyn, NY
- Active Since 10/30/2007
- Last Updated 11/10/2009
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1295914869
Products in Payments
- VOQUEZNA (Drug) $412.80
- DUPIXENT (Biological) $392.86
- MOUNJARO (Drug) $342.94
- Ozempic (Drug) $261.63
- AIRSUPRA (Drug) $250.00
- SOLIQUA 100/33 (Biological) $250.00
- Kerendia (Drug) $219.65
- Cologuard Collection Kit (Device) $219.42
- Pogo Automatic Blood Glucose Monitoring System (Device) $207.71
- BREZTRI (Drug) $197.97
- FARXIGA (Drug) $154.18
- Rybelsus (Drug) $125.00
- TOUJEO (Biological) $125.00
- Wegovy (Drug) $125.00
- RYBELSUS (Drug) $120.00
- JARDIANCE (Drug) $85.36
- XIFAXAN (Drug) $62.74
- PREVNAR 20 (Biological) $53.96
- TRULICITY (Drug) $52.54
- Veozah (Drug) $44.66
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Brooklyn
Susan Weiss, Np, NP
Family — Payments: $20,923
Ms. Abigail Hunter, Fnp, FNP
Family — Payments: $18,034
Seida Velija
Family — Payments: $15,903
Ami Lam
Family — Payments: $15,616
Christina Lao
Family — Payments: $15,127
Mrs. Kelly Morris, Fnp, FNP
Family — Payments: $8,415